L'expression tumorale de VEGF est-elle associée à l'envahissement veineux et à la survie dans les carcinomes du rein pT3 ?

25 avril 2007

Auteurs : Karim Bensalah, Nathalie Rioux-Leclercq, Sébastien Vincendeau, François Guille, Jean-Jacques Patard
Référence : Prog Urol, 2007, 2, 17, 189-193




 



Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser



References



Dhote R., Pellicer-Coeuret M., Thiounn N., Debre B., Vidal-Trecan G. Risk factors for adult renal cell carcinoma : a systematic review and implications for prevention BJU Int. 2000 ;  86 : 20-27
Griffiths D.F., Verghese A., Golash A., Kynaston H.G., Matthews P.N., Hart A.J., et al. Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma BJU Int. 2002 ;  90 : 26-31 [cross-ref]
Bensalah K., Guille F., Vincendeau S., Rioux-Leclercq N., Manunta A., Lobel B., et al. Facteurs pronostiques cliniques et anatomopathologiques des cancers du rein avec thrombus cave Progr. Urol. 2004 ;  14 : 160-166
Guinan P., Sobin L.H., Algaba F., Badellino F., Kameyama S., Maclennan G., et al. TNM staging of renal cell carcinoma : Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 1997 ;  80 : 992-993 [cross-ref]
Blath R.A., Mancilla-Jimenez R., Stanley R.J. Clinical comparison between vascular and avascular renal cell carcinoma J. Urol. 1976 ;  115 : 514-519
Gelb A.B., Sudilovsky D., Wu C.D., Weiss L.M., Medeiros L.J. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma Cancer 1997 ;  80 : 1768-1775 [cross-ref]
Tsui K.H., Shvarts O., Smith R.B., Figlin R.A., Dekernion J.B., Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria J. Urol. 2000 ;  163 : 1090-1095 [cross-ref]
Gettman M.T., Blute M.L., Spotts B., Bryant S.C., Zincke H. Pathologie staging of renal cell carcinoma : significance of tumor classification with the 1997 TNM staging System Cancer 2001 ;  91 : 354-361 [cross-ref]
Jacobsen J., Rasmuson T., Grankvist K., Ljungberg B. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma J. Urol. 2000 ;  163 : 343-347 [cross-ref]
Lein M., Jung K., Laube C., Hubner T., Winkelmann B., Ste- Phan C., et al. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma Int. J. Cancer 2000 ;  85 : 801-804 [cross-ref]
Katagiri A., Watanabe R., Tomita Y. E-cadherin expression in renal cell cancer and its significance in metastasis and survival Br. J. Cancer 1995 ;  71 : 376-379
Paradis V., Ferlicot S., Ghannam E., Zeimoura L., Blan- Chet P., Eschwege P., et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas J. Urol. 1999 ;  161 : 1984-1987 [cross-ref]
Edgren M., Lennernas B., Larsson A., Kalkner K.M. Angiogenic factors : vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma Anticancer Res. 2001 ;  21 : 1423-1429
Chang S.G., Jeon S.H., Lee S.J., Choi J.M., Kim Y.W. Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma Urology 2001 ;  58 : 904-908 [inter-ref]
Tomisawa M., Tokunaga T., Oshika Y., Tsuchida T., Fukushima Y., Sato H., et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma Eur. J. Cancer 1999 ;  35 : 133-137 [cross-ref]
Wechsel H.W., Bichler K.H., Feil G., Loeser W., Lahme S., Petri E. Renal cell carcinoma : relevance of angiogenetic factors Anticancer Res. 1999 ;  19 : 1537-1540
Nicol D., Hii S.I., Walsh M., Teh B., Thompson L., Kennett C. Vascular endothelial growth factor expression is increased in renal cell carcinoma J. Urol. 1997 ;  157 : 1482-1486 [cross-ref]
Motzer R.J., Michaelson M.D., Redman B.G., Hudes G.R., Wilding G., Figlin R.A., et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma J. Clin. Oncol. 2006 ;  157 : 16-24 [cross-ref]






© 2007 
Elsevier Masson SAS. Tous droits réservés.